{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:29:03Z","timestamp":1790710143393,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T00:00:00Z","timestamp":1613260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T00:00:00Z","timestamp":1613260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030313508"],"award-info":[{"award-number":["2017A030313508"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40744-021-00288-x","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T18:37:32Z","timestamp":1613673452000},"page":"517-527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Serum KL-6, CA19-9, CA125 and CEA are Diagnostic Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease in the Chinese Population"],"prefix":"10.1007","volume":"8","author":[{"given":"Muhan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiju","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weinan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,14]]},"reference":[{"issue":"23","key":"288_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205\u201319.","journal-title":"N Engl J Med"},{"issue":"8","key":"288_CR2","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, Williams P. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford). 2010;49(8):1483\u20139.","journal-title":"Rheumatology (Oxford)."},{"issue":"4","key":"288_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3899\/jrheum.171315","volume":"46","author":"K Raimundo","year":"2019","unstructured":"Raimundo K, Solomon JJ, Olson AL, Kong AM, Cole AL, Fischer A, Swigris JJ. Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality. J Rheumatol. 2019;46(4):360\u20139.","journal-title":"J Rheumatol"},{"issue":"10","key":"288_CR4","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/annrheumdis-2017-211138","volume":"76","author":"C Hyldgaard","year":"2017","unstructured":"Hyldgaard C, Hilberg O, Pedersen AB, Ulrichsen SP, Lokke A, Bendstrup E, Ellingsen T. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis. 2017;76(10):1700\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"288_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62(6):1583\u201391.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"288_CR6","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, Murphy J, Cohen M, Raghu G, Brown KK. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"288_CR7","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1093\/rheumatology\/kev204","volume":"54","author":"G De Luca","year":"2015","unstructured":"De Luca G, Bosello SL, Berardi G, Rucco M, Canestrari G, Correra M, Mirone L, Forni F, Di Mario C, Danza FM, Pirronti T, Ferraccioli G. Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk. Rheumatology (Oxford). 2015;54(11):1991\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"288_CR8","doi-asserted-by":"publisher","first-page":"204062232094480","DOI":"10.1177\/2040622320944802","volume":"11","author":"L Shi","year":"2020","unstructured":"Shi L, Han XL, Guo HX, Wang J, Tang YP, Gao C, Li XF. Increases in tumor markers are associated with primary Sjogren\u2019s syndrome-associated interstitial lung disease. Ther Adv Chronic Dis. 2020;11:2040622320944802.","journal-title":"Ther Adv Chronic Dis"},{"issue":"4","key":"288_CR9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.5606\/ArchRheumatol.2018.6691","volume":"33","author":"G Sargin","year":"2018","unstructured":"Sargin G, Kose R, Senturk T. Tumor-associated antigens in rheumatoid arthritis interstitial lung disease or malignancy? Arch Rheumatol. 2018;33(4):431\u20137.","journal-title":"Arch Rheumatol"},{"issue":"5 Pt 1","key":"288_CR10","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1164\/ajrccm.158.5.9803115","volume":"158","author":"A Yokoyama","year":"1998","unstructured":"Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, Hirasawa Y, Hiwada K. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1680\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"288_CR11","first-page":"4759040","volume":"2016","author":"K Hamai","year":"2016","unstructured":"Hamai K, Iwamoto H, Ishikawa N, Horimasu Y, Masuda T, Miyamoto S, Nakashima T, Ohshimo S, Fujitaka K, Hamada H, Hattori N, Kohno N. Comparative study of circulating MMP-7, CCL18, KL-6, SP-A, and SP-D as disease markers of idiopathic pulmonary fibrosis. Dis Mark. 2016;2016:4759040.","journal-title":"Dis Mark"},{"issue":"3","key":"288_CR12","doi-asserted-by":"publisher","first-page":"00019","DOI":"10.1183\/23120541.00019-2016","volume":"3","author":"A Sokai","year":"2017","unstructured":"Sokai A, Tanizawa K, Handa T, Kanatani K, Kubo T, Ikezoe K, Nakatsuka Y, Tokuda S, Oga T, Hirai T, Nagai S, Chin K, Mishima M. Importance of serial changes in biomarkers in idiopathic pulmonary fibrosis. ERJ Open Res. 2017;3(3):00019\u20132016.","journal-title":"ERJ Open Res."},{"issue":"3","key":"288_CR13","doi-asserted-by":"publisher","first-page":"e0229997","DOI":"10.1371\/journal.pone.0229997","volume":"15","author":"HC Kim","year":"2020","unstructured":"Kim HC, Choi KH, Jacob J, Song JW. Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease. PLoS ONE. 2020;15(3):e0229997.","journal-title":"PLoS ONE"},{"key":"288_CR14","first-page":"229","volume":"11","author":"I Amigues","year":"2019","unstructured":"Amigues I, Ramadurai D, Swigris JJ. Current perspectives on emerging biomarkers for rheumatoid arthritis-associated interstitial lung disease. Open Access Rheumatol Res Rev. 2019;11:229\u201335.","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"3","key":"288_CR15","first-page":"216","volume":"33","author":"YS Lee","year":"2016","unstructured":"Lee YS, Kim HC, Lee BY, Lee CK, Kim MY, Jang SJ, Lee HS, Moon J, Colby TV, Kim DS. The value of biomarkers as predictors of outcome in patients with rheumatoid arthritis-associated usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33(3):216\u201323.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"3","key":"288_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"key":"288_CR17","doi-asserted-by":"crossref","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjogren's S. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u2013558.","DOI":"10.1136\/ard.61.6.554"},{"issue":"6","key":"288_CR18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/14397595.2018.1467257","volume":"28","author":"H Sasaki","year":"2018","unstructured":"Sasaki H, Kohsaka H. Current diagnosis and treatment of polymyositis and dermatomyositis. Mod Rheumatol. 2018;28(6):913\u201321.","journal-title":"Mod Rheumatol"},{"issue":"11","key":"288_CR19","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Muller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Ellen Csuka M, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"288_CR20","doi-asserted-by":"crossref","unstructured":"Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ, Fibrosis AEJACoIP. An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788\u2013824.","DOI":"10.1164\/rccm.2009-040GL"},{"issue":"2","key":"288_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5271\/sjweh.596","volume":"27","author":"O Huuskonen","year":"2001","unstructured":"Huuskonen O, Kivisaari L, Zitting A, Taskinen K, Tossavainen A, Vehmas T. High-resolution computed tomography classification of lung fibrosis for patients with asbestos-related disease. Scand J Work Environ Health. 2001;27(2):106\u201312.","journal-title":"Scand J Work Environ Health"},{"issue":"7","key":"288_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejim.2013.07.004","volume":"24","author":"DN O'Dwyer","year":"2013","unstructured":"O\u2019Dwyer DN, Armstrong ME, Cooke G, Dodd JD, Veale DJ, Donnelly SC. Rheumatoid arthritis (RA) associated interstitial lung disease (ILD). Eur J Intern Med. 2013;24(7):597\u2013603.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"288_CR23","first-page":"587","volume":"34","author":"T Wang","year":"2016","unstructured":"Wang T, Zheng XJ, Ji YL, Liang ZA, Liang BM. Tumour markers in rheumatoid arthritis-associated interstitial lung disease. Clin Exp Rheumatol. 2016;34(4):587\u201391.","journal-title":"Clin Exp Rheumatol"},{"issue":"25","key":"288_CR24","doi-asserted-by":"publisher","first-page":"41412","DOI":"10.18632\/oncotarget.17916","volume":"8","author":"W Xiong","year":"2017","unstructured":"Xiong W, Zhao Y, Xu M, Guo J, Pudasaini B, Wu X, Liu J. The relationship between tumor markers and pulmonary embolism in lung cancer. Oncotarget. 2017;8(25):41412\u201321.","journal-title":"Oncotarget"},{"issue":"23","key":"288_CR25","doi-asserted-by":"publisher","first-page":"35423","DOI":"10.18632\/oncotarget.8770","volume":"7","author":"W Wang","year":"2016","unstructured":"Wang W, Chen XL, Zhao SY, Xu YH, Zhang WH, Liu K, Chen XZ, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK. Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma. Oncotarget. 2016;7(23):35423\u201336.","journal-title":"Oncotarget"},{"issue":"12","key":"288_CR26","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","volume":"5","author":"TM Maher","year":"2017","unstructured":"Maher TM, Oballa E, Simpson JK, Porte J, Habgood A, Fahy WA, Flynn A, Molyneaux PL, Braybrooke R, Divyateja H, Parfrey H, Rassl D, Russell AM, Saini G, Renzoni EA, Duggan AM, Hubbard R, Wells AU, Lukey PT, Marshall RP, Jenkins RG. An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study. Lancet Respir Med. 2017;5(12):946\u201355.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"288_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2177\/jsci.19.128","volume":"19","author":"S Yamamoto","year":"1996","unstructured":"Yamamoto S, Kobayashi S, Tanaka M, Akimoto T, Takasaki Y. Serum CA 19-9 levels in rheumatic diseases with interstitial pneumonia. Nihon Rinsho Meneki Gakkai Kaishi. 1996;19(2):128\u201335.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"5","key":"288_CR28","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1378\/chest.09-0510","volume":"136","author":"RM Strieter","year":"2009","unstructured":"Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest. 2009;136(5):1364\u201370.","journal-title":"Chest"},{"issue":"5","key":"288_CR29","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1365-2796.2006.01704.x","volume":"260","author":"H Satoh","year":"2006","unstructured":"Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med. 2006;260(5):429\u201334.","journal-title":"J Intern Med"},{"issue":"1","key":"288_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.resinv.2012.02.001","volume":"50","author":"N Ishikawa","year":"2012","unstructured":"Ishikawa N, Hattori N, Yokoyama A, Kohno N. Utility of KL-6\/MUC1 in the clinical management of interstitial lung diseases. Respir Investig. 2012;50(1):3\u201313.","journal-title":"Respir Investig"},{"issue":"6","key":"288_CR31","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1272\/jnms.81.364","volume":"81","author":"K Takahashi","year":"2014","unstructured":"Takahashi K, Nakamura H, Takenouchi K, Iizawa N, Koiwa M, Sato A, Mochizuki Y, Watanabe H, Takai S. Serum KL-6 elevation and possible pulmonary involvement in patients with rheumatoid arthritis treated with biological agents. J Nippon Med Sch. 2014;81(6):364\u201371.","journal-title":"J Nippon Med Sch"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40744-021-00288-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-021-00288-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T14:10:06Z","timestamp":1616595006000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40744-021-00288-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,14]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1007\/s40744-021-00288-x","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,14]]},"assertion":[{"value":"22 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}